Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in Erosive Mucosal Lichen Planus and Lichen Planopilaris
NCT07492251Phase 2Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of upadacitinib in lichen planus (LP), lichen planopilaris (LPP), sponsored by Centre Hospitalier Universitaire de Nice. Started Oct 2026; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
lichen planus (LP)lichen planopilaris (LPP)
Beyond the preview
Go deeper on NCT07492251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07492251.